Skip to main content

Impact of detecting and treating exercise-induced bronchoconstriction in elite footballers

Jackson, Anna R., Hull, James H., Hopker, James G., Dickinson, John W. (2018) Impact of detecting and treating exercise-induced bronchoconstriction in elite footballers. European Respiratory Journal Open Research, 4 (2). ISSN 2312-0541. E-ISSN 2312-0541. (doi:10.1183/23120541.00122-2017) (KAR id:66834)

PDF Publisher pdf
Language: English


Download (285kB) Preview
[thumbnail of 00122-2017.full.pdf]
Preview
This file may not be suitable for users of assistive technology.
Request an accessible format
Official URL
http://dx.doi.org/10.1183/23120541.00122-2017

Abstract

Our aim was to evaluate the prevalence of exercise-induced bronchoconstriction (EIB) in elite football players and assess subsequent impact of therapy on airway health and exercise performance. 97 male professional football players completed an airway health assessment with a eucapnic voluntary hyperpnoea (EVH) challenge to diagnose EIB. Players demonstrating a positive result (EVH+) were prescribed inhaler therapy depending on severity, including inhaled corticosteroids and inhaled short-acting β2-agonists, and underwent repeat assessment after 9 weeks of treatment. Eight players (EVH+ n=3, EVH− n=5) completed a peak oxygen uptake (V′O2peak) test at initial and follow-up assessment. Out of the 97 players, 27 (28%) demonstrated a positive EVH result. Of these, 10 had no prior history (37%) of EIB or asthma. EVH outcome was not predictable by respiratory symptoms. Seven (24%) of the 27 EVH+ players attended follow-up and demonstrated improved post-challenge spirometry (forced expiratory volume in 1 s pre-test −22.9±15.4%, post-test −9.0±1.6%; p=0.018). At follow-up V′O2peak improved by 3.4±2.9 mL·kg−1·min−1 in EVH+ players compared to 0.1±2.3 mL·kg−1·min−1 in EVH− players. Magnitude of inference analysis indicated treatment was possibly beneficial (74%) for exercise capacity.

Elite football players have a high EIB prevalence. Treatment with inhaler therapy reduces EIB severity.

Item Type: Article
DOI/Identification number: 10.1183/23120541.00122-2017
Subjects: R Medicine > RC Internal medicine > RC1200 Sports medicine
Divisions: Divisions > Division of Natural Sciences > School of Sport and Exercise Sciences
Depositing User: John Dickinson
Date Deposited: 24 Apr 2018 11:31 UTC
Last Modified: 16 Feb 2021 13:54 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/66834 (The current URI for this page, for reference purposes)
Hopker, James G.: https://orcid.org/0000-0002-4786-7037
Dickinson, John W.: https://orcid.org/0000-0002-1824-7402
  • Depositors only (login required):

Downloads

Downloads per month over past year